Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest
Balance at beginning of period (in shares) at Dec. 31, 2021		74,427,000
Balance at beginning of period at Dec. 31, 2021	$ 748,275	$ 744	$ 826,718	$ (79,420)	$ (28)	$ 261
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,256)			(2,236)		(20)
Foreign currency translation adjustments	6				6
Equity-based compensation	5,599		5,599
Issuance of common stock pursuant to equity incentive plans (in shares)		53,000
Issuance of common stock pursuant to equity incentive plans	0	$ 1	(1)
Balance at end of period (in shares) at Apr. 01, 2022		74,480,000
Balance at end of period at Apr. 01, 2022	751,624	$ 745	832,316	(81,656)	(22)	241
Balance at beginning of period (in shares) at Dec. 31, 2021		74,427,000
Balance at beginning of period at Dec. 31, 2021	$ 748,275	$ 744	826,718	(79,420)	(28)	261
Balance at end of period (in shares) at Dec. 30, 2022	75,042,000	75,042,000
Balance at end of period at Dec. 30, 2022	$ 757,171	$ 750	848,703	(88,046)	(4,236)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(14,548)			(14,548)
Foreign currency translation adjustments	253				253
Equity-based compensation	7,577		7,577
Repurchase and retirement of common stock (in shares)		(27,000)
Repurchase and retirement of common stock	(238)		(238)
Issuance of common stock pursuant to equity incentive plans (in shares)		332,000
Issuance of common stock pursuant to equity incentive plans	0	$ 3	(3)
Tax withholding on net share settlement of equity awards (in shares)		(95,000)
Tax withholding on net share settlement of equity awards	(1,024)	$ (1)	(1,023)
Employee stock purchase plan	$ 186		186
Balance at end of period (in shares) at Mar. 31, 2023	75,252,000	75,252,000
Balance at end of period at Mar. 31, 2023	$ 749,377	$ 752	$ 855,202	$ (102,594)	$ (3,983)	$ 0